Oxidative Stress in Kidney Diseases: The Cause or the Consequence?

被引:89
作者
Krata, Natalia [1 ]
Zagozdzon, Radoslaw [1 ,2 ,3 ]
Foroncewicz, Bartosz [1 ]
Mucha, Krzysztof [1 ,2 ]
机构
[1] Med Univ Warsaw, Dept Immunol Transplantol & Internal Dis, Nowogrodzka 59, PL-02006 Warsaw, Poland
[2] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland
[3] Med Univ Warsaw, Dept Clin Immunol, Warsaw, Poland
基金
欧盟地平线“2020”;
关键词
Oxidative stress; Biomarkers; Chronic kidney disease; GELATINASE-ASSOCIATED LIPOCALIN; PERITONEAL-DIALYSIS PATIENTS; CHRONIC-RENAL-FAILURE; ALPHA-KETOGLUTARATE; N-ACETYLCYSTEINE; VITAMIN-E; IN-VIVO; MAINTENANCE HEMODIALYSIS; ANTIOXIDANT CAPACITY; NONDIABETIC PATIENTS;
D O I
10.1007/s00005-017-0496-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Exaggerated oxidative stress (OS) is usually considered as a disturbance in regular function of an organism. The excessive levels of OS mediators may lead to major damage within the organism's cells and tissues. Therefore, the OS-associated biomarkers may be considered as new diagnostic tools of various diseases. In nephrology, researchers are looking for alternative methods replacing the renal biopsy in patients with suspicion of chronic kidney disease (CKD). Currently, CKD is a frequent health problem in world population, which can lead to progressive loss of kidney function and eventually to end-stage renal disease. The course of CKD depends on the primary disease. It is assumed that one of the factors influencing the course of CKD might be OS. In the current work, we review whether monitoring the OS-associated biomarkers in nephrology patients can support the decision-making process regarding diagnosis, prognostication and treatment initiation.
引用
收藏
页码:211 / 220
页数:10
相关论文
共 100 条
[91]   Correlates of markers of oxidative status in the general population [J].
Trevisan, M ;
Browne, R ;
Ram, M ;
Muti, P ;
Freudenheim, J ;
Carosella, AM ;
Armstrong, D .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 154 (04) :348-356
[92]   Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma [J].
Trzeciecka, Anna ;
Klossowski, Szymon ;
Bajor, Malgorzata ;
Zagozdzon, Radoslaw ;
Gaj, Pawel ;
Muchowicz, Angelika ;
Malinowska, Agata ;
Czerwoniec, Anna ;
Barankiewicz, Joanna ;
Domagala, Antoni ;
Chlebowska, Justyna ;
Prochorec-Sobieszek, Monika ;
Winiarska, Magdalena ;
Ostaszewski, Ryszard ;
Gwizdalska, Iwonna ;
Golab, Jakub ;
Nowis, Dominika ;
Firczuk, Malgorzata .
ONCOTARGET, 2016, 7 (02) :1717-1731
[93]   Chronic Kidney Disease Influences Multiple Systems: Describing the Relationship between Oxidative Stress, Inflammation, Kidney Damage, and Concomitant Disease [J].
Tucker, Patrick S. ;
Scanlan, Aaron T. ;
Dalbo, Vincent J. .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2015, 2015
[94]   Indoxyl Sulfate Upregulates Expression of ICAM-1 and MCP-1 by Oxidative Stress-Induced NF-κB Activation [J].
Tumur, Zohra ;
Shimizu, Hidehisa ;
Enomoto, Atsushi ;
Miyazaki, Hitoshi ;
Niwa, Toshimitsu .
AMERICAN JOURNAL OF NEPHROLOGY, 2010, 31 (05) :435-441
[95]   Risk Factors and Screening for Chronic Kidney Disease [J].
Vassalotti, Joseph A. ;
Fox, Chester H. ;
Becker, Bryan N. .
ADVANCES IN CHRONIC KIDNEY DISEASE, 2010, 17 (03) :237-245
[96]   Oxidative stress in uremia: Nature, mechanisms, and potential consequences [J].
Vaziri, ND .
SEMINARS IN NEPHROLOGY, 2004, 24 (05) :469-473
[97]   Oxidized LDL, statin use, morbidity, and mortality in patients receiving maintenance hemodialysis [J].
Wagner, Sandra ;
Apetrii, Mugurel ;
Massy, Ziad A. ;
Kleber, Marcus E. ;
Delgado, Graciela E. ;
Scharnagel, Hubert ;
Maerz, Winfried ;
Metzger, Marie ;
Rossignol, Patrick ;
Jardine, Alan ;
Holdaas, Hallvard ;
Fellstroem, Bengt ;
Schmieder, Roland ;
Stengel, Benedicte ;
Zannad, Faiez .
FREE RADICAL RESEARCH, 2017, 51 (01) :14-23
[98]   Redox Sensing by Proteins: Oxidative Modifications on Cysteines and the Consequent Events [J].
Wang, Ying ;
Yang, Jie ;
Yi, Jing .
ANTIOXIDANTS & REDOX SIGNALING, 2012, 16 (07) :649-657
[99]   Alpha-Ketoglutarate as a Molecule with Pleiotropic Activity: Well-Known and Novel Possibilities of Therapeutic Use [J].
Zdzisinska, Barbara ;
Zurek, Aleksandra ;
Kandefer-Szerszen, Martyna .
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2017, 65 (01) :21-36
[100]   Association between myeloperoxidase levels and risk of coronary artery disease [J].
Zhang, ZL ;
Brennan, ML ;
Fu, XM ;
Aviles, RJ ;
Pearce, GL ;
Penn, MS ;
Topol, EJ ;
Sprecher, DL ;
Hazen, SL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (17) :2136-2142